0000059478-24-000164.txt : 20240710 0000059478-24-000164.hdr.sgml : 20240710 20240710084020 ACCESSION NUMBER: 0000059478-24-000164 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240705 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240710 DATE AS OF CHANGE: 20240710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 241108756 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 8-K 1 lly-20240705.htm 8-K lly-20240705
0000059478false00000594782024-07-052024-07-050000059478us-gaap:CommonClassAMember2024-07-052024-07-050000059478lly:A718NotesDueJune12025Member2024-07-052024-07-050000059478lly:A1.625NotesDueJune22026Member2024-07-052024-07-050000059478lly:A2.125NotesDueJune32030Member2024-07-052024-07-050000059478lly:A625Notesdue2031Member2024-07-052024-07-050000059478lly:A500NotesDue2033Member2024-07-052024-07-050000059478lly:A6.77NotesDueJanuary12036Member2024-07-052024-07-050000059478lly:A1625NotesDue2043Member2024-07-052024-07-050000059478lly:A1.700Notesdue2049Member2024-07-052024-07-050000059478lly:A1125NotesDue2051Member2024-07-052024-07-050000059478lly:A1375NotesDue2061Member2024-07-052024-07-05

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): July 5, 2024
ELI LILLY AND COMPANY
(Exact Name of Registrant as Specified in its Charter) 
Indiana 001-06351 35-0470950
(State or Other Jurisdiction
of Incorporation)		 (Commission
File Number)		 (I.R.S. Employer
Identification No.)
  


Lilly Corporate Center
Indianapolis,Indiana46285
(Address of Principal Executive Offices)(Zip Code)
Registrant’s Telephone Number, Including Area Code: (317) 276-2000

Not Applicable
(Former Name or Former Address, if Changed Since Last Report.) 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock (no par value)LLYNew York Stock Exchange
7 1/8% Notes due 2025LLY25New York Stock Exchange
1.625% Notes due 2026LLY26New York Stock Exchange
2.125% Notes due 2030LLY30New York Stock Exchange
0.625% Notes due 2031LLY31New York Stock Exchange
0.500% Notes due 2033LLY33New York Stock Exchange
6.77% Notes due 2036LLY36New York Stock Exchange
1.625% Notes due 2043LLY43New York Stock Exchange
1.700% Notes due 2049LLY49ANew York Stock Exchange
1.125% Notes due 2051LLY51New York Stock Exchange
1.375% Notes due 2061LLY61New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐






Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On June 5, 2024, Eli Lilly and Company (the “Company”) announced that Anat Ashkenazi resigned as executive vice president and chief financial officer of the Company to pursue another career opportunity outside of the pharmaceutical industry. Effective July 15, 2024, Gordon Brooks, age 55, group vice president, controller and corporate strategy, of the Company, will assume the role of interim chief financial officer of the Company.

During his 29-year career with the Company, Mr. Brooks has held various leadership roles across the Company’s finance organization, including as senior vice president, chief procurement officer, from February 2019 to March 2024, prior to becoming the group vice president, controller and corporate strategy. Previous finance leadership roles held by Mr. Brooks include chief financial officer for Lilly U.S. Bio-Medicines, chief financial officer of manufacturing and quality, leader of the Company’s corporate finance investment banking group, and general auditor.

There are no arrangements or understandings between Mr. Brooks and any person pursuant to which Mr. Brooks was selected as an officer. There is no family relationship between Mr. Brooks and any director or executive officer of the Company, and Mr. Brooks is not a party to any transaction subject to Item 404(a) of Regulation S-K involving the Company or any of its subsidiaries.

Ms. Ashkenazi will remain at the Company through the end of July 2024 to facilitate the transition of her responsibilities.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ELI LILLY AND COMPANY
(Registrant)
By:/s/ Anat Hakim
Name:Anat Hakim
Title:Executive Vice President, General Counsel and
Secretary
Date: July 10, 2024

 EX-101.SCH 2 lly-20240705.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 lly-20240705_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 4 lly-20240705_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 1.125% Notes due 2051 1.125% Notes due 2051 [Member] 1.125% Notes due 2051 1.625% Notes due 2043 1.625% Notes due 2043 [Member] 1.625% Notes due 2043 1.625% Notes due 2026 1.625% Notes Due June 2, 2026 [Member] 1.625% Notes Due June 2, 2026 [Member] 1.700% Notes due 2049 1.700% Notes due 2049 [Member] 1.700% Notes due 2049 [Member] Document Period End Date Document Period End Date 1.375% Notes due 2061 1.375% Notes due 2061 [Member] 1.375% Notes due 2061 Pre-commencement Tender Offer Pre-commencement Tender Offer Class of Stock [Domain] Class of Stock [Domain] Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code 6.77% Notes due 2036 6.77% Notes Due January 1, 2036 [Member] 6.77% Notes Due January 1, 2036 [Member] 7 1/8% Notes due 2025 7 1/8% Notes Due June 1, 2025 [Member] 7 1/8% Notes Due June 1, 2025 [Member] Entity Central Index Key Entity Central Index Key 2.125% Notes due 2030 2.125% Notes Due June 3, 2030 [Member] 2.125% Notes Due June 3, 2030 [Member] Entity Address, City or Town Entity Address, City or Town .500% Notes due 2033 .500% Notes due 2033 [Member] .500% Notes due 2033 Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Document Information [Line Items] Document Information [Line Items] Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Cover [Abstract] Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common Stock (no par value) Common Class A [Member] Document Type Document Type Amendment Flag Amendment Flag 0.625% Notes due 2031 .625% Notes due 2031 [Member] .625% Notes due 2031 [Member] Class of Stock [Axis] Class of Stock [Axis] Document Information [Table] Document Information [Table] Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 5 lly-20240705_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.2
Cover Page
Jul. 05, 2024
Document Information [Line Items]  
Document Type 8-K
Document Period End Date Jul. 05, 2024
Entity Incorporation, State or Country Code IN
Entity File Number 001-06351
Entity Tax Identification Number 35-0470950
Entity Address, Address Line One Lilly Corporate Center
Entity Address, City or Town Indianapolis,
Entity Address, State or Province IN
Entity Address, Postal Zip Code 46285
City Area Code 317
Local Phone Number 276-2000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Registrant Name ELI LILLY AND COMPANY
Entity Central Index Key 0000059478
Amendment Flag false
Entity Emerging Growth Company false
Common Stock (no par value)  
Document Information [Line Items]  
Title of 12(b) Security Common Stock (no par value)
Trading Symbol LLY
Security Exchange Name NYSE
7 1/8% Notes due 2025  
Document Information [Line Items]  
Title of 12(b) Security 7 1/8% Notes due 2025
Trading Symbol LLY25
Security Exchange Name NYSE
1.625% Notes due 2026  
Document Information [Line Items]  
Title of 12(b) Security 1.625% Notes due 2026
Trading Symbol LLY26
Security Exchange Name NYSE
2.125% Notes due 2030  
Document Information [Line Items]  
Title of 12(b) Security 2.125% Notes due 2030
Trading Symbol LLY30
Security Exchange Name NYSE
0.625% Notes due 2031  
Document Information [Line Items]  
Title of 12(b) Security 0.625% Notes due 2031
Trading Symbol LLY31
Security Exchange Name NYSE
6.77% Notes due 2036  
Document Information [Line Items]  
Title of 12(b) Security 6.77% Notes due 2036
Trading Symbol LLY36
Security Exchange Name NYSE
1.700% Notes due 2049  
Document Information [Line Items]  
Title of 12(b) Security 1.700% Notes due 2049
Trading Symbol LLY49A
Security Exchange Name NYSE
.500% Notes due 2033  
Document Information [Line Items]  
Title of 12(b) Security 0.500% Notes due 2033
Trading Symbol LLY33
Security Exchange Name NYSE
1.625% Notes due 2043  
Document Information [Line Items]  
Title of 12(b) Security 1.625% Notes due 2043
Trading Symbol LLY43
Security Exchange Name NYSE
1.125% Notes due 2051  
Document Information [Line Items]  
Title of 12(b) Security 1.125% Notes due 2051
Trading Symbol LLY51
Security Exchange Name NYSE
1.375% Notes due 2061  
Document Information [Line Items]  
Title of 12(b) Security 1.375% Notes due 2061
Trading Symbol LLY61
Security Exchange Name NYSE
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2 html 12 22 1 false 11 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.lilly.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports lly-20240705.htm lly-20240705.xsd lly-20240705_def.xml lly-20240705_lab.xml lly-20240705_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "lly-20240705.htm": { "nsprefix": "lly", "nsuri": "http://www.lilly.com/20240705", "dts": { "inline": { "local": [ "lly-20240705.htm" ] }, "schema": { "local": [ "lly-20240705.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "lly-20240705_def.xml" ] }, "labelLink": { "local": [ "lly-20240705_lab.xml" ] }, "presentationLink": { "local": [ "lly-20240705_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 10, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 12, "entityCount": 1, "segmentCount": 11, "elementCount": 38, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 52 }, "report": { "R1": { "role": "http://www.lilly.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "lly-20240705.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "lly-20240705.htm", "first": true, "unique": true } } }, "tag": { "lly_A1.625NotesDueJune22026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.lilly.com/20240705", "localname": "A1.625NotesDueJune22026Member", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.625% Notes due 2026", "label": "1.625% Notes Due June 2, 2026 [Member]", "documentation": "1.625% Notes Due June 2, 2026 [Member]" } } }, "auth_ref": [] }, "lly_A1.700Notesdue2049Member": { "xbrltype": "domainItemType", "nsuri": "http://www.lilly.com/20240705", "localname": "A1.700Notesdue2049Member", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.700% Notes due 2049", "label": "1.700% Notes due 2049 [Member]", "documentation": "1.700% Notes due 2049 [Member]" } } }, "auth_ref": [] }, "lly_A1125NotesDue2051Member": { "xbrltype": "domainItemType", "nsuri": "http://www.lilly.com/20240705", "localname": "A1125NotesDue2051Member", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.125% Notes due 2051", "label": "1.125% Notes due 2051 [Member]", "documentation": "1.125% Notes due 2051" } } }, "auth_ref": [] }, "lly_A1375NotesDue2061Member": { "xbrltype": "domainItemType", "nsuri": "http://www.lilly.com/20240705", "localname": "A1375NotesDue2061Member", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.375% Notes due 2061", "label": "1.375% Notes due 2061 [Member]", "documentation": "1.375% Notes due 2061" } } }, "auth_ref": [] }, "lly_A1625NotesDue2043Member": { "xbrltype": "domainItemType", "nsuri": "http://www.lilly.com/20240705", "localname": "A1625NotesDue2043Member", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.625% Notes due 2043", "label": "1.625% Notes due 2043 [Member]", "documentation": "1.625% Notes due 2043" } } }, "auth_ref": [] }, "lly_A2.125NotesDueJune32030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.lilly.com/20240705", "localname": "A2.125NotesDueJune32030Member", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "2.125% Notes due 2030", "label": "2.125% Notes Due June 3, 2030 [Member]", "documentation": "2.125% Notes Due June 3, 2030 [Member]" } } }, "auth_ref": [] }, "lly_A500NotesDue2033Member": { "xbrltype": "domainItemType", "nsuri": "http://www.lilly.com/20240705", "localname": "A500NotesDue2033Member", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": ".500% Notes due 2033", "label": ".500% Notes due 2033 [Member]", "documentation": ".500% Notes due 2033" } } }, "auth_ref": [] }, "lly_A6.77NotesDueJanuary12036Member": { "xbrltype": "domainItemType", "nsuri": "http://www.lilly.com/20240705", "localname": "A6.77NotesDueJanuary12036Member", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "6.77% Notes due 2036", "label": "6.77%\u00a0Notes Due January\u00a01, 2036 [Member]", "documentation": "6.77%\u00a0Notes Due January\u00a01, 2036 [Member]" } } }, "auth_ref": [] }, "lly_A625Notesdue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.lilly.com/20240705", "localname": "A625Notesdue2031Member", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "0.625% Notes due 2031", "label": ".625% Notes due 2031 [Member]", "documentation": ".625% Notes due 2031 [Member]" } } }, "auth_ref": [] }, "lly_A718NotesDueJune12025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.lilly.com/20240705", "localname": "A718NotesDueJune12025Member", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "7 1/8% Notes due 2025", "label": "7 1/8% Notes Due June\u00a01, 2025 [Member]", "documentation": "7 1/8% Notes Due June\u00a01, 2025 [Member]" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassAMember", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock (no par value)", "label": "Common Class A [Member]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.lilly.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0000059478-24-000164-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000059478-24-000164-xbrl.zip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end XML 16 lly-20240705_htm.xml IDEA: XBRL DOCUMENT 0000059478 2024-07-05 2024-07-05 0000059478 us-gaap:CommonClassAMember 2024-07-05 2024-07-05 0000059478 lly:A718NotesDueJune12025Member 2024-07-05 2024-07-05 0000059478 lly:A1.625NotesDueJune22026Member 2024-07-05 2024-07-05 0000059478 lly:A2.125NotesDueJune32030Member 2024-07-05 2024-07-05 0000059478 lly:A625Notesdue2031Member 2024-07-05 2024-07-05 0000059478 lly:A500NotesDue2033Member 2024-07-05 2024-07-05 0000059478 lly:A6.77NotesDueJanuary12036Member 2024-07-05 2024-07-05 0000059478 lly:A1625NotesDue2043Member 2024-07-05 2024-07-05 0000059478 lly:A1.700Notesdue2049Member 2024-07-05 2024-07-05 0000059478 lly:A1125NotesDue2051Member 2024-07-05 2024-07-05 0000059478 lly:A1375NotesDue2061Member 2024-07-05 2024-07-05 0000059478 false 8-K 2024-07-05 ELI LILLY AND COMPANY IN 001-06351 35-0470950 Lilly Corporate Center Indianapolis, IN 46285 317 276-2000 false false false false Common Stock (no par value) LLY NYSE 7 1/8% Notes due 2025 LLY25 NYSE 1.625% Notes due 2026 LLY26 NYSE 2.125% Notes due 2030 LLY30 NYSE 0.625% Notes due 2031 LLY31 NYSE 0.500% Notes due 2033 LLY33 NYSE 6.77% Notes due 2036 LLY36 NYSE 1.625% Notes due 2043 LLY43 NYSE 1.700% Notes due 2049 LLY49A NYSE 1.125% Notes due 2051 LLY51 NYSE 1.375% Notes due 2061 LLY61 NYSE false